BioPharma Resources

Drug Trial Radar · NCT06963580

Efficacy of MI078 Capsules in Treating Postpartum Depression

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of MI078 Capsule in Patients With Postpartum Depression

Last checked: Nov 19, 2026Latest source record: Jun 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

72

Actual

Start

Sep 9, 2024

Primary completion

Aug 7, 2025

Study completion Aug 7, 2025

Sponsor

Sponsor type
Industry
First posted
May 9, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 18 years, up to 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a multicenter, randomized, double-blind, placebo-controlled trial. It includes three groups. Each group will enroll 24 participants. The trial aims todetermine: To evaluate the efficacy of MI078 capsules in treating postpartum depression and to explore the optimal dosing regimen for MI078 capsules. To assess the safety of MI078 capsules in postpartum depression patients.

Conditions

  • Postpartum Depression

Interventions

  • MI078 capsule dose 1Drug

    MI078 capsule dose 1 for 3 days

  • MI078 capsule dose 2Drug

    MI078 capsule dose 2 for 3 days

  • placeboDrug

    placebo for 3 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in HAM-D17 total scoreTime frame: up to day 31

Locations

21 sites in 1 country. Site status is shown where the registry gives one.

  • The Affiliated Beijing Anding Hospital of Capital Medical University, Wuhu Hospital

    Wuhu, Anhui, China

  • Beijing HuiLongGuan Hospital

    Beijing, Beijing Municipality, China

  • Xiamen Xian Yue Hospital

    Xiamen, Fujian, China

  • Shunde Hospital of Southern Medical University

    Foshan, Guangdong, China

  • The First Affiliated Hospital of Jinan University

    Guangzhou, Guangdong, China

  • Guangxi Zhuang Autonomous Region People's Hospital

    Nanning, Guangxi, China

  • The People's Hospital of Guizhou Province

    Guiyang, Guizhou, China

  • The First Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China

  • Xingtai People's Hospital

    Xingtai, Hebei, China

  • The First Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, China

  • Shanghai Mental Health Center

    Shanghai, Shanghai Municipality, China

  • Shanghai Pudong New Area Mental Health Center

    Shanghai, Shanghai Municipality, China

  • Linfen Central Hospital

    Linfen, Shanxi, China

  • The First Hospital of Shanxi Medical University

    Taiyuan, Shanxi, China

  • Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital

    Chengdu, Sichuan, China

  • First Affiliated Hospital of Kunming Medical University

    Kunming, Yunnan, China

  • The First People's Hospital of Hangzhou

    Hangzhou, Zhejiang, China

  • The Second Affiliated Hospital of Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China

  • The Affiliated Kangning Hospital of Ningbo University

    Ningbo, Zhejiang, China

  • The First Affiliated Hospital of Ningbo University

    Ningbo, Zhejiang, China

  • The First Affiliated Hospital of Wenzhou Medical University

    Wenzhou, Zhejiang, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.